|
Top Highlights
Johnson & Johnson, an American multinational pharmaceutical, biotechnology, and medical technologies corporation, agreed to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, for $14.6bn.
Intra-Cellular Therapies is advised by Centerview Partners, Jefferies & Company and Davis Polk & Wardwell (led by Michael Davis and Lee Hochbaum). Johnson & Johnson is advised by Citigroup and Cravath Swaine & Moore. Centerview is advised by Skadden Arps Slate Meagher & Flom (led by Graham Robinson).
Clearwater Analytics, a SaaS fintech company, agreed to acquire Enfusion, an investment management SaaS platform provider, for $1.5bn.
Clearwater is advised by JP Morgan and Kirkland & Ellis (led by Constantine Skarvelis). Enfusion is advised by Goldman Sachs, Dechert and Goodwin Procter (led by Gregg Katz). Debt financing is provided by JP Morgan.
Lantheus, a radiopharmaceutical-focused company, agreed to acquire Life Molecular Imaging, a global radiopharmaceutical company dedicated to developing and offering novel cutting-edge radiopharmaceuticals, for $400m.
Life Molecular is advised by FirstRand Bank, A&O Shearman and Cliffe Dekker Hofmeyr. Lantheus is advised by Ernst & Young, Morgan Stanley, Bowmans, Covington & Burling and Ropes & Gray.
Deal Round up
AMERICAS
Venture Global targets $110bn valuation in landmark IPO. ( SEC Filing)
EMEA
Germany explores sale of Uniper stake after nationalization. ( Reuters)
South African regulator urges African Rainbow Capital to divest produce agency stake. ( Bloomberg)
APAC
Yinson nears investor commitments for $1.5bn funding round. ( Bloomberg)
CATL prepares for major Hong Kong listing with top banks as lead arrangers. ( Bloomberg)
Macquarie Asset Management appoints Gabriel Ho as managing director for Southeast Asia. ( FSA)
|
COMPANIES
INVESTORS
FINANCIAL ADVISORS
LEGAL ADVISORS
PR ADVISORS
|
|
Read on...
Scroll down to read deal descriptions. Your suggestions and comments support the democratisation of M&A data. If you'd like to contribute to the future editions, drop us a line.
AMERICAS
Aura Minerals, a multi-national mining company that owns and operates gold and copper mines, completed the acquisition of Bluestone Resources, a Canadian-based precious metals exploration and development company, for $74m.
Bluestone Resources was advised by GenCap Mining Advisory, Blake Cassels & Graydon, Paul Weiss Rifkind Wharton & Garrison (led by Christopher Cummings) and Stikeman Elliott. Aura Minerals was advised by Dorsey & Whitney and Gowling WLG (led by France Tenaille and Ian Mitchell).
Eli Lilly, an American multinational pharmaceutical company, agreed to acquire Scorpion Therapeutics, a clinical-stage, precision oncology biotechnology company, for $2.5bn.
Eli Lilly is advised by Citigroup and Ropes & Gray. Scorpion Therapeutics is advised by Centerview Partners, Morgan Stanley and Kirkland & Ellis.
GTCR, a private equity firm, completed the investment in Winged Keel Group, an independent life insurance brokerage firm. Financial terms were not disclosed.
Winged Keel Group was advised by Houlihan Lokey, Finn Dixon & Herling and Foley Hoag. GTCR was advised by Ardea Partners and Simpson Thacher & Bartlett.
Apollo, a provider of alternative asset management and retirement solutions, agreed to acquire Argo Infrastructure Partners, a mid-market asset manager targeting essential infrastructure assets in North America. Financial terms were not disclosed.
Argo Infrastructure Partners is advised by Fenchurch Advisory Partners, Latham & Watkins and Edelman (led by Ira Gorsky). Apollo Global is advised by Paul Weiss Rifkind Wharton & Garrison (led by David C. Hepp and Joseph Glatt).
GSK, a British multinational pharmaceutical and biotechnology company, agreed to acquire IDRx, a Boston-based, clinical-stage biopharmaceutical company, for $1.15bn.
Pelican Energy Partners, a highly specialized private equity fund, completed the acquisition of Lancs Industries, a provider of radiation containment and shielding solutions. Financial terms were not disclosed.
Lancs Industries was advised by Cairncross & Hempelmann. Pelican Energy Partners was advised by McGuireWoods.
Pershing Square, an American hedge fund management company, is set to invest an additional $1bn in Howard Hughes, a real estate development and management company.
ADIA, a sovereign wealth fund owned by the Emirate of Abu Dhabi, agreed to invest $500m in AlphaGen, a critical power infrastructure owner and operator.
New Enterprise Associates, Yosemite, Regeneron Ventures and Hevolution Foundation led a $175m funding round in Tune Therapeutics, an epigenome editing company.
Venture Global targets $110bn valuation in landmark IPO. (SEC Filing)
Venture Global, a liquefied natural gas exporter, is aiming for a valuation of up to $110.38bn in its US initial public offering. This marks the potential first blockbuster IPO of 2025.
Based in Arlington, Virginia, the company plans to raise as much as $2.30bn through the offering. If successful, it would be the largest energy company listing in New York in over a decade, signaling a strong start to the year for the IPO market.
EMEA
AustralianSuper, an Australian superannuation fund, agreed to acquire a 50% stake in a logistics real estate portfolio from Oxford Properties, the real estate arm of the Ontario Municipal Employees Retirement System, at a €840m ($860m) valuation.
AustralianSuper is advised by Savills. Oxford Properties is advised by Eastdil Secured.
ADQ, a sovereign wealth fund based in Abu Dhabi, offered to acquire Aramex, an Emirati multinational logistics, courier and package delivery company, for $1.2bn.
ADQ is advised by Rothschild & Co.
Regeneron, a biopharmaceutical company, led a $320m Series C round in Truveta, a collective of US health systems delivering electronic health record data, with participation from Illumina.
Germany explores sale of Uniper stake after nationalization. ( Reuters)
Berlin is exploring potential buyers for Uniper, the $18.8bn energy utility, in a move that could involve selling the government’s entire stake. Germany currently owns 99.12% of Uniper, having nationalized the company in 2022 during Europe’s energy crisis.
While the government’s preferred option is a partial stake sale or a re-IPO involving approximately 25% of the company, it is also considering a full exit from its holding in a single transaction. Discussions remain preliminary, and no final decision has been made.
South African regulator urges African Rainbow Capital to divest produce agency stake. ( Bloomberg)
South Africa's antitrust regulator has recommended that African Rainbow Capital, backed by billionaire Patrice Motsepe, divest its stake in one of the nation’s largest fresh agricultural produce agencies, citing anti-competitive practices.
The Competition Commission highlighted that African Rainbow Capital holds substantial stakes in both the RSA Group and Subtropico, which together control between 50% and 90% of South African markets for staple fruits and vegetables, including potatoes, apples, bananas, onions, and tomatoes. The regulator argues that this dominance is hindering market competition.
EG Group, the petrol station operator backed by private equity firm TDR Capital, is preparing for an initial public offering in New York as early as this year, with a potential valuation of around $13bn.
The IPO would allow TDR Capital to partially divest its investment in the company, which it first entered into more than a decade ago in partnership with Blackburn’s billionaire Issa brothers, Zuber and Mohsin.
APAC
Shares of Australia's Insignia Financial have surged to their highest level in over three years as a bidding war between private equity firms Bain Capital and CC Capital intensified. Bain Capital raised its offer for Insignia Financial to AUD2.87bn ($1.76bn), matching CC Capital's bid.
The revised offer values Insignia shares at AUD4.30 ($2.64) each, a 7.5% premium over Bain's previous offer and a 4.4% premium above the last closing price of AUD4.12 ($2.54).
Insignia Financial is advised by Citigroup, Gresham and King & Wood Mallesons.
PAG, an Asia-focused alternative investment firm, completed the acquisition of a majority stake in Pravesha, a largest pharma-focused packaging company. Financial terms were not disclosed.
Yinson nears investor commitments for $1.5bn funding round. ( Bloomberg)
Malaysian energy infrastructure firm Yinson is close to securing investors for a significant funding round in its unit specializing in offshore oil and gas equipment.
Abu Dhabi Investment Authority, British Columbia Investment Management, and RRJ Capital are expected to commit $1bn in redeemable convertible preference shares as early as this week. The same investors are anticipated to contribute an additional $500m at a later, yet-to-be-determined date.
Philippine fintech company GCash has enlisted banks, including Citi, Jefferies, and UBS, to lead its domestic initial public offering worth up to $1.5bn. If successful, this would mark the largest stock offering in the country’s history.
The IPO is anticipated to take place as early as the second half of 2025 or in 2026, contingent on favorable market conditions.
CATL prepares for major Hong Kong listing with top banks as lead arrangers. ( Bloomberg)
Contemporary Amperex Technology is set to appoint Bank of America, China International Capital, CSC Financial, and JP Morgan as lead arrangers for its upcoming secondary listing in Hong Kong.
The listing could become one of the largest offerings in Hong Kong in recent years. Additional banks are expected to join the effort.
Macquarie Asset Management appoints Gabriel Ho as managing director for Southeast Asia. ( FSA)
Macquarie Asset Management has announced the appointment of Gabriel Ho as managing director to bolster its investment activities in Southeast Asia.
With 17 years of investment experience, Ho brings a wealth of expertise to the Australian asset manager. Prior to joining Macquarie, he served as a partner and investment committee member at Dymon Asia Private Equity, a private equity fund focused on Southeast Asia.
|
Connect the World of Dealmakers
Expand your network of fellow Dealmakers by inviting your colleagues and coworkers.
Join Now
If you know someone who might enjoy this briefing forward this email. Subscribe to a Daily Review.
|
|
|
|
|